Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Immune Cell Function and Interaction, and CAR-T cell therapy research.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old
Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines
Publisher Correction: Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder